America August 25, 2025
AbbVie to Acquire Gilgamesh’s Bretisilocin in $1.2B Psychedelic Bet
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
America August 25, 2025
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
By Rihem Akkouche
America June 19, 2023
A groundbreaking research study conducted by the University of Haifa and the Max Stern Yezreel Valley College in Israel has…
By Jackie Allen
And More April 30, 2022
Elon Musk was hit with backlash after tweeting on Friday that the antidepressant Wellbutrin is “way worse than Adderall” and…
By Rochdi Rais